Valneva working on remediation plan for COVID-19 vaccine candidate

French drugmaker Valneva said on Friday it had proposed a remediation plan after receiving the European Commission's notice of intent to terminate the advance purchase agreement for its inactivated COVID-19 vaccine candidate. 'Some member states have confirmed their interest in having an inactivated, adjuvanted whole-virus vaccine solution in their portfolio,' the company said in a statement.